Longitudinal assessment of the ultrasound gout lesions using the validated OMERACT semi-quantitative scoring system. c

Abstract

Background In gout, ultrasound (US) is a promising tool to detect changes in monosodium urate (MSU) depositions during urate-lowering therapy (ULT). The OMERACT US group has developed definitions of gout-specific US lesions[1] and a semi-quantitative scoring system for US lesions representing MSU deposition (tophus, double contour (DC) and aggregates)[2], but the responsiveness of lesions when applying this scoring system has not yet been assessed.


Original languageEnglish
Publication date2022
Publication statusPublished - 2022
EventEULAR 2022 - Copenhagen
Duration: 1 Jun 20224 Jun 2022

Conference

ConferenceEULAR 2022
CityCopenhagen
Period01/06/202204/06/2022

Cite this